Skip Navigation



IJE Advance Access published online on March 11, 2004

International Journal of Epidemiology, doi:10.1093/ije/dyh102
© 2004 by International Epidemiological Association
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/5/955    most recent
dyh102v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sparks, R.
Right arrow Articles by Ulrich, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sparks, R.
Right arrow Articles by Ulrich, C. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Accepted December 19, 2003

Original paper

TGF{beta}1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps

Rachel Sparks 1, Jeannette Bigler 2, Justin G. Sibert 2, John D. Potter 1, Yutaka Yasui 2, Cornelia M. Ulrich 1*

1 Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, USA; Department of Epidemiology, University of Washington, Seattle, Washington, 98195, USA
2 Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, USA

* To whom correspondence should be addressed. E-mail: nulrich{at}fhcrc.org.


   Abstract

Background Transforming growth factor-{beta}1 (TGF{beta}1) is a multifunctional signalling molecule with a wide array of roles. Animal experiments suggest that TGF{beta}1 plays a biphasic role in carcinogenesis by protecting against the early formation of benign epithelial growths, but promoting malignant transformation of those growths that do develop. A polymorphism in the signal peptide sequence of the TGF{beta}1 gene (L10P) has been associated with increased levels of plasma TGF{beta}1 in individuals with the P allele.

Methods We investigated whether this polymorphism was associated with the risk of colorectal adenomatous or hyperplastic polyps in a case-control study of individuals from Minnesota. Risk of colorectal polyps was evaluated separately for individuals with adenomatous polyps (n = 513) and hyperplastic polyps (n = 191) relative to polyp-free controls (n = 606) using logistic regression analysis.

Results No overall association was seen between the L10P polymorphism and risk of colorectal adenomatous polyps. The age- and sex-adjusted odds ratios (OR) of developing colorectal hyperplastic polyps were 1.0 (95% CI: 0.7, 1.4) and 0.7 (95% CI: 0.4, 1.1) for individuals with the LP and PP genotypes, respectively, compared with individuals with the LL genotype. When stratified by smoking, evidence for a decreased risk of hyperplastic polyps associated with the P allele was seen only among ever smokers (P for trend = 0.05).

Conclusions Whereas adenoma risk did not vary by TGF{beta}1 L10P genotype, these results suggest that the L10P variant allele may have a protective role in the development of colorectal hyperplastic polyps, possibly consistent with its role as an inhibitor of epithelial growths.

Keywords Colorectal cancer, colorectal adenoma, transforming growth factor beta, polymorphism, smoking, aspirin, non-steroidal anti-inflammatory drugs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
E. Botteri, S. Iodice, V. Bagnardi, S. Raimondi, A. B. Lowenfels, and P. Maisonneuve
Smoking and Colorectal Cancer: A Meta-analysis
JAMA, December 17, 2008; 300(23): 2765 - 2778.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. S. Saltzman, J. F. Yamamoto, R. Decker, L. Yokochi, A. G. Theriault, T. M. Vogt, and L. Le Marchand
Association of Genetic Variation in the Transforming Growth Factor {beta}-1 Gene with Serum Levels and Risk of Colorectal Neoplasia
Cancer Res., February 15, 2008; 68(4): 1236 - 1244.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. I. Berndt, W.-Y. Huang, N. Chatterjee, M. Yeager, R. Welch, S. J. Chanock, J. L. Weissfeld, R. E. Schoen, and R. B. Hayes
Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
Carcinogenesis, September 1, 2007; 28(9): 1965 - 1970.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. M. Poole, J. Bigler, J. Whitton, J. G. Sibert, J. D. Potter, and C. M. Ulrich
Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 502 - 508.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Ulrich, J. Whitton, J.-H. Yu, J. Sibert, R. Sparks, J. D. Potter, and J. Bigler
PTGS2 (COX-2) -765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 616 - 619.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
G. Davey Smith
Genetic epidemiology: an 'enlightened narrative'?
Int. J. Epidemiol., October 1, 2004; 33(5): 923 - 924.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
L. J Palmer
The New Epidemiology: putting the pieces together in complex disease aetiology
Int. J. Epidemiol., October 1, 2004; 33(5): 925 - 928.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.